Key facts
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share (RCUS).
- Disclosed ownership: 4.1%.
- Date of event: 30 Sep 2025.
Point72 Asset Management, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share (RCUS)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- RCUS
- Shares outstanding
- 105,670,220 shares
- Disclosed Ownership
- 4,332,479 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:07:41 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 13 May 2025
- SEC
- View on sec.gov
Key filing fact
Point72 Asset Management, L.P. disclosed 4.1% ownership in Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share (RCUS) on 30 Sep 2025.
Change
- Previous schedule filing date: 13 May 2025.
- Current filing was accepted on 14 Nov 2025, 16:07.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 4.1% | 4,332,479 | 0 | 4,332,479 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 4.1% | 4,332,479 | 0 | 4,332,479 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 4.1% | 4,332,479 | 0 | 4,332,479 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |
CIK / CUSIP context first